$11.5M Deal In Investor’s Off-Label Promotion Scheme Suit Gets Initial Nod

Mealey's (September 19, 2022, 2:09 PM EDT) -- BROOKLYN, N.Y. — A federal judge in New York on Sept. 15 ruled that a proposed $11.5 million settlement between a pension fund and a biopharmaceutical company and its CEO in a class action lawsuit alleging that the defendants engaged in an illegal off-label promotion scheme in violation of federal securities law is fair, reasonable and adequate and preliminarily meets the factors for approval....

Attached Documents

Related Sections